Search Results - "Navarro‐Partida, José"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Educación en línea y enfermedad del ojo seco durante la pandemia de COVID-19 by Francisco J. Santa Cruz-Pavlovich, Andrés J. Bolaños-Chang, Juan E. González-González, Jesús F. Guzmán-Castellanos, Roberto A. Ledesma-Mijares, Héctor Fuentes-Plata, Citlalli Jiménez-Batalla, José Navarro-Partida

    Published in Revista mexicana de oftalmología (01-12-2022)
    “…Objetivo: Analizar los cambios en la frecuencia y la incidencia de la enfermedad del ojo seco (EOS) y los tiempos de exposición a pantallas al inicio de cursos…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Therapies Based on Nanoparticles for Eye Drug Delivery by Meza-Rios, Alejandra, Navarro-Partida, Jose, Armendariz-Borunda, Juan, Santos, Arturo

    Published in Ophthalmology and therapy (07-05-2020)
    “…Eye drug delivery, particularly to the retina, is a technical hurdle that needs to be solved and represents an ongoing current important medical field…”
    Get full text
    Journal Article
  14. 14

    Polymeric Implants for the Treatment of Intraocular Eye Diseases: Trends in Biodegradable and Non-Biodegradable Materials by García-Estrada, Paulina, García-Bon, Miguel A., López-Naranjo, Edgar J., Basaldúa-Pérez, Dulce N., Santos, Arturo, Navarro-Partida, Jose

    Published in Pharmaceutics (12-05-2021)
    “…Intraocular/Intravitreal implants constitute a relatively new method to treat eye diseases successfully due to the possibility of releasing drugs in a…”
    Get full text
    Journal Article
  15. 15

    Nutraceuticals: A Promising Therapeutic Approach in Ophthalmology by Castro-Castaneda, Carlos Rodrigo, Altamirano-Lamarque, Francisco, Ortega-Macías, Alan Gabriel, Santa Cruz-Pavlovich, Francisco J, Gonzalez-De la Rosa, Alejandro, Armendariz-Borunda, Juan, Santos, Arturo, Navarro-Partida, Jose

    Published in Nutrients (25-11-2022)
    “…Oxidative stress represents one of the main factors driving the pathophysiology of multiple ophthalmic conditions including presbyopia, cataracts, dry eye…”
    Get full text
    Journal Article
  16. 16

    Lipid-Based Nanocarriers as Topical Drug Delivery Systems for Intraocular Diseases by Navarro-Partida, Jose, Castro-Castaneda, Carlos Rodrigo, Santa Cruz-Pavlovich, Francisco J., Aceves-Franco, Luis Abraham, Guy, Tomer Ori, Santos, Arturo

    Published in Pharmaceutics (09-05-2021)
    “…Effective drug delivery to intraocular tissues remains a great challenge due to complex anatomical and physiological barriers that selectively limit the entry…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    The multifaceted role of pirfenidone and its novel targets by Macías-Barragán, José, Sandoval-Rodríguez, Ana, Navarro-Partida, Jose, Armendáriz-Borunda, Juan

    Published in Fibrogenesis & tissue repair (01-09-2010)
    “…Pirfenidone (PFD) is a molecule that exhibits antifibrotic properties in a variety of in vitro and animal models of lung, liver and renal fibrosis. These…”
    Get full text
    Journal Article